This study, called the BostonGene-Integrated Genomic Registry (BIGR), is building a large database of information from people with cancer (malignancy). The goal is to understand how your genes (genomic), how your genes are expressed (transcriptomic), and other molecular features relate to your cancer and how you respond to treatments. By collecting this detailed information along with your treatment history, researchers hope to find new ways to improve future cancer care. You can join if you are 18 or older, have suspected or confirmed cancer, and have had or plan to have detailed genetic testing. You also need to be willing to be contacted in the future to share information about your cancer outcomes and treatment. The study aims to enroll 100,000 participants, but its current recruitment status is unclear.

Study design

This is an observational study, meaning researchers will collect information without giving any specific treatments. It aims to include 100,000 participants.

What's involved

You will not have any extra scans or procedures for this study. Researchers will collect your clinical and genetic information, and you will need to be willing to be contacted in the future for updates on your cancer outcomes and treatment.

Compensation

Not stated in the trial record.

Follow-up

Your outcomes will be measured for up to 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.